Regeneron Pharmaceuticals, Inc.

REGN.MX·Mexico·Healthcare
Compare
18,330.000.00 (0.00%)today
At close: Nov 3, 2:02 PM CST · May be delayed up to 20 min · MXN

Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close18,330.00
Open18,271.19
Day range0.0018,330.00
52-week range0.0018,330.00
Off day high0.00%
Off 52-week high0.00%
Volume0.00
Avg. volume (3M)54.00
Market cap1.90T
EPS (TTM)798.49
Forward P/E—
P/E ratio (TTM)22.96
Dividend yield0.39% (70.78)
Beta (5Y)0.10
Shares outstanding101.63M
Short interest—
Earnings dateOct 30, 2026 (est.)
Analyst target—
Profit margin28.51%

Against its peers

Compare in full ›
REGN.MX 214450.KQ 068270.KS BIOCON.NS 9995.HK ROIV
Market cap 1.90T 2.34T 49.02T 592.87B 40.23B 27.61B
P/E (TTM) 23.0 — — 121.5 6.1 —
Forward P/E — — — 33.3 46.7 -27.5
Price/book 2.9 — — 1.7 3.8 6.5
Dividend yield 0.39% 1.66% 0.36% 0.15% — —
1-year change +50.80% −56.00% +20.07% −10.58% −19.94% +85.85%
Today 0.00% +0.67% +7.50% +5.10% +1.49% +6.08%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.

Latest news

All REGN.MX news ›
Trefis·

Is Regeneron Stock Increasing Your Market Risk?

If you hold Regeneron Pharmaceuticals (REGN) or plan to, its 19.0% rise from October 26 to November 2, 2026, while the S&P 500 fell 1.8%, likely caught your eye. Your other money probably already follows the market, so how Regeneron…

Trefis·Positive

Was There Any Sign Regeneron Stock Would Run?

An investor who bought a $10,000 stake in Regeneron Pharmaceuticals (REGN) at the October 31, 2025 close held about $15,010 on November 3, 2026. The company’s sales growth picked up over those twelve months. Management says most of the…

JournalArta·Positive

REGN Stock Gains 3.60%, RSI Overbought In Focus

JournalArta REGN Stock Gains 3.60%, RSI Overbought In Focus On November 2, 2026: price 961.26 USD, trend uptrend, RSI 81.9, support 738.72, resistance 961.26. technical analysis of regn stock. REGN Stock Gains — full… Why REGN is in focus…

european-biotechnology.com·Positive

Beyond monoclonals: Multispecific antibodies

New biologic logic – Multispecific antibodies extend targeted therapy beyond one antigen or pathway. By combining binding sites, cell recruitment and defined valencies within one molecule, they enable mechanisms that conventional…

From the 4Search news index, newest first.

In the news

317mentions in 30 days
82with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance